JTE-051
Sponsors
Akros Pharma Inc.
Conditions
Plaque PsoriasisRheumatoid ArthritisSkin Diseases
Phase 2
Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis
CompletedNCT02919475
Start: 2016-09-14End: 2018-06-25Updated: 2021-06-14
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
TerminatedNCT03358290
Start: 2017-11-10End: 2018-10-29Updated: 2021-08-06